On Friday, Restaurant Brands International Inc (NYSE:QSR)’s shares declined -0.92% to $37.85.
The BURGER KING® brand is owned by Restaurant Brands International Inc (NYSE:QSR). The BURGER KING McLAMORESM Foundation declared recently that it is making the dreams of close to 2,500 students a reality. Through its BURGER KINGSM Scholars program, $2.7 million in scholarships — counting three $50,000 grants — are being awarded to exceptional high school graduates and BK® employees in the U.S., Canada and Puerto Rico.
Recognizing thousands of world-changing students through various scholarship levels, the program opens countless doors for students across North America, putting college within their reach and allowing them to seize unprecedented opportunities.
It all began in 2000, when BURGER KING® franchisees initiated the program. Since then, the BURGER KINGSM Scholars program—administered by the BURGER KING McLAMORESM Foundation since 2005—has touched the lives of more than 24,000 students, awarding $25.3 million in financial assistance to be used toward their educational advancement. This year alone, the program awarded three $50,000 James W. McLamore WHOPPER® Scholarship Awards, 10 $5,000 regional scholarships and close to 2,500 $1,000 scholarships to graduates.
These extraordinary students carry on the legacy of BURGER KING® brand co-founder James W. McLamore, the inspiration for the Foundation and a committed philanthropist whose dedication to education made him a pillar of community service throughout his lifetime.
Restaurant Brands International Inc. owns and operates quick service restaurants under the Burger King and Tim Hortons brand names. As of February 17, 2015, it franchised or owned 19,043 restaurants in about 100 countries and U.S. territories worldwide. The company was founded in 1954 and is headquartered in Oakville, Canada.
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO)’s shares dropped -4.81% to $1.98.
AVEO Pharmaceuticals, Inc. (AVEO) declared that it has received written feedback from the U.S. Food and Drug Administration regarding a potential pivotal study for tivozanib in the treatment of NRP-1 low colorectal cancer (CRC). Tivozanib is an oral, potent, selective inhibitor of vascular endothelial growth factor (VEGF) with a long half-life and activity against all three VEGF receptors.
AVEO recently presented results from the BATON-CRC study, a 265 patient randomized trial exploring the combination of mFOLFOX6 and tivozanib or bevacizumab as first-line treatment in patients with advanced metastatic CRC, at the 2015 American Association for Cancer Research (AACR) Tumor Angiogenesis and Vascular Normalization Conference. Among the predefined biomarkers explored in this study, neuropilin-1 (NRP-1), a signaling protein known to bind to VEGF-A in serum, was found to be a potential prognostic marker for angiogenesis inhibitor activity and may be predictive of tivozanib activity relative to bevacizumab.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, develops targeted therapies for patients with cancer and related diseases. Its product candidates under development comprise Tivozanib, an tyrosine kinase inhibitor for various vascular endothelial growth factors; Ficlatuzumab, a hepatocyte growth factor inhibitory antibody, which has accomplished Phase II trial; and AV-203, an anti-ErbB3 monoclonal antibody that has accomplished a Phase I dose escalation study.
At the end of Friday’s trade, LKQ Corporation (NASDAQ:LKQ)‘s shares surged 0.37% to $29.69.
LKQ Corporation (LKQ) has again been named to the Fortune 500 list, Fortune magazine’s annual ranking of America’s largest companies by revenue. LKQ had 2014 total revenue of $6.7 billion. Fortune magazine ranked LKQ No. 403 on its list contrast to No. 490 last year.
LKQ Corporation, together with its auxiliaries, distributes replacement parts, components, and systems used in the repair and maintenance of vehicles in the United States, the United Kingdom, the Netherlands, Belgium, Northern France, Canada, Mexico, and Central America. The company operates in four segments: Wholesale North America, Wholesale Europe, Self Service, and Specialty. It distributes various products, counting aftermarket collision and mechanical products; recycled collision and mechanical products; and refurbished collision replacement products, such as wheels, bumper covers and lights, and remanufactured engines.
Media General Inc (NYSE:MEG), ended its Friday’s trading session with 1.67% gain, and closed at $17.06.
Media General Inc (MEG) declared that Steve Watt has been designated Vice President and General Manager of WKRN-TV, its ABC associate in Nashville, Tennessee.
Mr. Watt was promoted to this position after serving as the station’s General Sales Manager since 2008. During his tenure, he successfully built WKRN-TV’s brand recognition with advertisers, developed innovative sales strategies, and led the sales organization through a period of unprecedented growth. He will succeed Stan Knott who was elevated to Vice President of Broadcast Markets for Media General.
Commenting on the declarement, Deborah A. McDermott, Chief Operating Officer for Media General, said: “Steve is a highly planned and skilled broadcast executive who has been involved in every aspect of WKRN’s operation. He brings a forward-thinking approach to news, sales and promotions across all screens. He also has a genuine, heartfelt commitment to meeting the needs of our viewers and advertisers. He is the ideal candidate and very deserving of this promotion.
Media General, Inc. owns and operates television stations in the United States. It operates 71 network-associated stations, and their associated digital media and mobile platforms, counting 22 CBS stations, 14 NBC stations, 12 ABC stations, 8 FOX stations, 7 MyNetworkTV stations, 7 CW stations, and 1 Telemundo station in 48 markets.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
